Targeted News Service WASHINGTON, May 14 The Department of Health & Human Services published the following notice in the Federal Register from the Food & Drug Administration: Agency Information Collection Activities; Announcement of Office of ... Pharmacy Choice, 1 week ago
Nectar Lifesciences, the fast-growing manufacturer of generic pharmaceutical active pharmaceutical ingredients (APIs) and formulation products has received ANVISA cGMP (Current Good Manufacturing Practices) approval for Brazil for its Cephalosporin ...Indian-Commodity, 1 week ago Nectar Lifesciences gains on receiving ANVISA cGMP approval for Cephalosporin API's manufacturing facility Finalaya.com, 1 week ago Beximco Pharmaceuticals Release: Results For The Year Ended 31 December 2014 BioSpace, 2 weeks ago
Are you interested in the FDA's guidance on outsourcing facilities? Your time to comment is ending soon!
The Food and Drug Administration (FDA) has issued five draft documents addressing outsource facility registration ; repackaging of human drug products ; mixing, diluting, or repackaging biologic products ; adverse event reporting for outsourcing ...Lexology, 1 week ago FDA Allows More Time to Comment on Food Safety Modernisation Act The Beef Site, 2 weeks ago Taking baked goods safely into the future Snack Food & Wholesale Bakery, 2 weeks ago
Operator Good afternoon, and welcome to the Atossa Genetics Earnings Conference Call for the First Quarter Ended March 31, 2015. All participants will be in listen-only mode. [Operator Instructions] After today's presentation, there will be an ...Seeking Alpha, 2 weeks ago Vericel's (VCEL) CEO Nick Colangelo on Q1 2015 Results - Earnings Call Transcript Seeking Alpha, 1 week ago Guided Therapeutics' (GTHP) CEO Gene Cartwright on Q1 2015 Results - Earnings Call Transcript Seeking Alpha, 1 week ago
WASHINGTON, May 6 (Reuters) - The U.S. Food and Drug Administration will hold a public meeting this summer to address drug company concern that restrictions on what they can say about off-label use of drugs violate their first amendment right to ...CNBC, 3 weeks ago RPT-Under pressure, FDA to hold public meeting on off-label use Reuters UK, 2 weeks ago REFILE-Under pressure, FDA to hold public meeting on off-label use Reuters UK, 3 weeks ago
As it announced the beginning of its integration with Ranbaxy, Dilip Shanghvi, Sun Pharmaceuticals’ managing director, spoke to Abhineet Kumar and Reghu Balakrishnan about challenges and strategy. Excerpts: Will value be created for Sun Pharmaceuticals from generics or the speciality business? The focus for value creation will be on all business segments, including speciality, generics (branded, complex, pure) and active pharmaceutical ingredients. Also the consumer health ...Rediff.com, 2 months ago
Boston, MA Wasatch-Contract-Manufacturing Territorial Office Announces It Was Presented Most Accurate "Contract Manufacturer" (April 2015) for "Custom Dental-Care Formulations"
This press release was orginally distributed by ReleaseWire Boston, MA -- (ReleaseWire) -- 05/12/2015 -- Wasatch Product Development is focused on providing the most responsive and flexible service in the industry and has a diverse clientele ...Digital Journal, 2 weeks ago San Francisco, CA Wasatch-Contract-Manufacturing Local Office Announces Adam Green Will Chair the June 30th "Utah Contract Manufacturing" Anti-Aging Serum "Liquid-Contractor" Symposium from Clarkston Digital Journal, 1 week ago Stockton, CA Wasatch-Contract-Manufacturing Neighborhood Office Announces Adam Green Will Chair the June 11th "Utah Contract Manufacturing" Anti-Aging Serum "Liquid-Contractor" Symposium from Brigham CEOWorld Magazine, 2 weeks ago Chula Vista, CA Wasatch-Contract-Manufacturing Regional Office Announces It Was Presented Most Dependable "Liquid-Contractor" (March 2015) for "Custom Crème Formulations" A.M. Best, 1 week ago
By Rapid changes in the drug industry are affecting glaucoma practices, said Andrew G. Iwach, MD, who provided an overview of these trends. It's an interesting time right now. Among the most important trends in glaucoma medications is the rise of ...Ophthalmology Times, 1 week ago
by Medical device executives share best practices on launching medical devices at MedTech Investing Conference in the Twin Cities At a time when the regulatory barriers put up by the Food and Drug Administration seem to be easing a bit, ...MassDevice, 2 weeks ago European union: Medtec brings a new Start-Up Academy to Medtec Europe Medical Plastics News, 1 week ago Cogentix Medical Reports Fourth Quarter and Full Year Fiscal 2015 Results TickerTech.com, 1 week ago Isolating medical devices Connecting Industry, 1 week ago
Provectus Poster on PV-10 Clinical Data from Phase 1 Study for Cancers of the Liver Presentation; FDA Grants Orphan Drug Designation To GlycoMimetics' GMI-1271
Below is a look at some of the headlines for companies that made news in the healthcare sector on May 13, 2015. Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT) , a clinical-stage oncology and dermatology biopharmaceutical company, ...BioMedReports, 1 week ago
on your WebpageAdd Widget >Get your members hooked!